Posts by Sandra Ansanay-Alex
ONWARD’s Neurostimulator Restores Mobility for Patients with Spinal Cord Injury
This is the first time the ARCIM is used on a human patient. This implantable pulse generator (IPG) stimulates the spinal cord to restore movement and autonomic functions for people with spinal cord injury and other conditions that affect mobility. This first implant on a human patient is a major milestone in ONWARD’s successful…
Read MoreHemostOD creates ex vivo blood platelets
HemostOD has developed a solution for ex vivo on-demand production of blood platelets. The company just received a CHF 100 000 Tech Seed loan from the Foundation for Technological Innovation (FIT). Worldwide, 10 million platelet concentrates are transfused each year. Platelets are small blood cells whose function is to stop bleeding. Today, patients can only…
Read MoreSwiss biotech companies attracted investments of $3.33 billion in 2021
Last year was ‘the second best year in terms of fundraising’, according to the Swiss Biotech Association. The sector benefited from a “still strong” international contribution. Of the $3.33 billion, $2.51 billion was invested in listed companies, including Sophia Genetics in Lausanne, with $234 million following its initial public offering (IPO) and its follow-up,…
Read MoreSwiss Medtech Day
The Swiss Medtech Day is taking place on 9 June 2027 in Kursaal, Bern. The overarching theme for 2024-2026 is Mastering Complexity. This theme addresses the dynamic changes in the world and the challenges faced by the medical technology industry. The Swiss Medtech Day provides a platform for discussing these challenges. By sharing experiences, best…
Read MorePodcast: Claude Clément
BioAlps President, Claude Clément, discusses career choices and how to lead innovation in the healthcare industry in the podcast What To Do Next? Claude Clément first worked in R&D for the watch industry (Swatch Group🇨🇭), then entered the world of medical technologies by heading the diversification activities of Swatch in the field of wearable programmable drug delivery…
Read MoreMerck Serono improves quality control with IA
Artificial Intelligence helps to assess the severity of a manufacturing incident in a medicine production unit In any factory, every day, a problem occurs. But when it happens at a site that manufactures cancer or multiple sclerosis drugs, the consequences can turn into a catastrophe. In order to make the right decisions as quickly…
Read MoreEUR 1 million Eurostars grant for Limula and Ceidos
The two swiss biotech startups signed an agreement with Stemmatters in Portugal. They received a Eurostars grant of EUR 1.14 million to merge their expertise to develop platforms for the automated production of cell and gene therapy products. Chimeric antigen receptor (CAR) T-cell therapies have shown exceptional clinical efficacy for the treatment of multiple…
Read MoreSwitzerland is high on the financing of medical startups
Switzerland ranks fourth in Europe in terms of the number of deals behind Britain, Germany and France. Last year, investments in startups reached CHF 2.78 billion, half the amount in 2020 according to a survey by EY Switzerland Venture capital. In terms of volume, Switzerland is the seventh-largest country in Europe. The number of…
Read MorePlair SA raised CHF 2,7 million
A grant to fund the Rapid-C Real-Time Microbial Detector Plair SA, based in Plan-les-Ouates, Geneva, has been awarded CHF 2.7 million in funding from the State Secretariat for Education, Research and Innovation SERI and the EIC Accelerator (former SME Instrument), a highly competitive programme of the European Commission offering funding, coaching and business acceleration services…
Read MoreArtiria Medical raised CHF 3.8 million to improve stroke treatment
Artiria Medical, a swiss neurovascular start-up, raised CHF 3.8 M, including a CHF 2.7 M grant from the highly selective EIC accelerator program and a CHF 1.1 M bridge financing. With its breakthrough technology, Artiria Medical has been awarded the highly selective EIC Accelerator Grant supporting disruptive innovation across Europe, funded by the Swiss State…
Read More